Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224132967> ?p ?o ?g. }
- W4224132967 abstract "Abstract Background Psoriasis and psoriatic arthritis are common immune-mediated inflammatory conditions that primarily affect the skin, joints and entheses and can lead to significant disability and worsening quality of life. Although early recognition and treatment can prevent the development of permanent damage, psoriatic disease remains underdiagnosed and undertreated due in part to the disparity between disease prevalence and relative lack of access to clinical specialists in dermatology and rheumatology. Remote patient self-assessment aided by smartphone sensor technology may be able to address these gaps in care, however, these innovative disease measurements require robust clinical validation. Methods We developed smartphone-based assessments, collectively named the Psorcast suite, that can be self-administered to measure cutaneous and musculoskeletal signs and symptoms of psoriatic disease. The image and motion sensor data collected by these assessments was processed to generate digital biomarkers or machine learning models to detect psoriatic disease phenotypes. To evaluate these digital endpoints, a cross-sectional, in-clinic validation study was performed with 92 participants across two specialized academic sites consisting of healthy controls and participants diagnosed with psoriasis and/or psoriatic arthritis. Findings In the domain of skin disease, digital patient assessment of percent body surface area (BSA) affected with psoriasis demonstrated very strong concordance (CCC = 0·94, [95%CI = 0·91–0·96]) with physician-assessed BSA. Patient-captured psoriatic plaque photos were remotely assessed by physicians and compared to in-clinic Physician Global Assessment parameters for the same plaque with fair to moderate concordance (CCC erythema =0·72 [0·59–0·85]; CCC induration =0·72 [0·62–0·82]; CCC scaling =0·60 [0·48–0·72]). Arm range of motion was measured by the Digital Jar Open assessment to classify physician-assessed upper extremity involvement with joint tenderness or enthesitis, demonstrating an AUROC = 0·68 (0·47–0·85). Patient-captured hand photos were processed with object detection and deep learning models to classify clinically-diagnosed nail psoriasis with an accuracy of 0·76, which is on par with remote physician rating of nail images (avg. accuracy = 0·63) with model performance maintaining accuracy when raters were too unsure or image quality was too poor for a remote assessment. Interpretation The Psorcast digital assessments, performed by patient self-measurement, achieve significant clinical validity when compared to in-person physical exams. These assessments should be considered appropriately validated for self-monitoring and exploratory research applications, particularly those that require frequent, remote disease measurements. However, further validation in larger cohorts will be necessary to demonstrate robustness and generalizability across populations for use in evidence-based medicine or clinical trial settings. The smartphone software and analysis pipelines from the Psorcast suite are open source and available to the scientific community. Funding This work is funded by the Psorcast Digital Biomarker Consortium consisting of Sage Bionetworks, Psoriasis and Psoriatic Arthritis Centers for Multicenter Advancement Network (PPACMAN), Novartis, UCB, Pfizer, and Janssen Pharmaceuticals. J.U.S work was supported by the Snyder Family Foundation and the Riley Family Foundation. Research in context Evidence before this study No systematic literature review was performed. Patient self-measurement with smartphone sensors has been shown to be clinically valid for assessing signs and symptoms such as tremor, gait, physical activity, or range of motion across multiple disease indications. While smartphone-based applications have been developed for digitally tracking psoriatic disease, they have largely focused on questionnaire-based patient reported outcomes. Added value of this study To our knowledge, Psorcast is the first application using ubiquitous smartphone sensor technology for patients to remotely measure their psoriatic disease phenotypes, including detection of nail psoriasis and a continuous variable outcome measure of joint tenderness and enthesitis based on range of motion. This study not only developed a suite of novel, smartphone sensor-based assessment that can be self-administered to measure cutaneous and musculoskeletal signs and symptoms, but provides clinical validation of these measures. Implications of all the available evidence The developed Psorcas t suite of measurements can serve as groundwork for patient-driven, remote measurement of psoriatic disease. The use and continued development of this technology opens up new possibilities for both clinical care and research endeavors on a large scale. Psorcast measurements are currently being validated for their ability to assess disease changes longitudinally, allowing for more frequent symptom monitoring in clinical trials, more granular insight into the time course of medication action, and possible identification of responders from non-responders to specific therapies." @default.
- W4224132967 created "2022-04-20" @default.
- W4224132967 creator A5003658474 @default.
- W4224132967 creator A5010908187 @default.
- W4224132967 creator A5014427334 @default.
- W4224132967 creator A5016395305 @default.
- W4224132967 creator A5018137195 @default.
- W4224132967 creator A5021010552 @default.
- W4224132967 creator A5021220009 @default.
- W4224132967 creator A5024781162 @default.
- W4224132967 creator A5029959684 @default.
- W4224132967 creator A5030104352 @default.
- W4224132967 creator A5032924701 @default.
- W4224132967 creator A5038454932 @default.
- W4224132967 creator A5040068787 @default.
- W4224132967 creator A5043550255 @default.
- W4224132967 creator A5044993439 @default.
- W4224132967 creator A5048701330 @default.
- W4224132967 creator A5054208950 @default.
- W4224132967 creator A5059452001 @default.
- W4224132967 creator A5065048859 @default.
- W4224132967 creator A5067254549 @default.
- W4224132967 creator A5067824626 @default.
- W4224132967 creator A5068442243 @default.
- W4224132967 creator A5075617884 @default.
- W4224132967 creator A5084752178 @default.
- W4224132967 creator A5086701229 @default.
- W4224132967 creator A5091295638 @default.
- W4224132967 creator A5091871404 @default.
- W4224132967 date "2022-04-16" @default.
- W4224132967 modified "2023-10-16" @default.
- W4224132967 title "Clinical validation of digital biomarkers and machine learning models for remote measurement of psoriasis and psoriatic arthritis" @default.
- W4224132967 cites W1683131358 @default.
- W4224132967 cites W2003716133 @default.
- W4224132967 cites W2006617902 @default.
- W4224132967 cites W2008223306 @default.
- W4224132967 cites W2014804217 @default.
- W4224132967 cites W2036607940 @default.
- W4224132967 cites W2046607138 @default.
- W4224132967 cites W2058547807 @default.
- W4224132967 cites W2080165152 @default.
- W4224132967 cites W2103120331 @default.
- W4224132967 cites W2122980756 @default.
- W4224132967 cites W2145532966 @default.
- W4224132967 cites W2159505902 @default.
- W4224132967 cites W2167606334 @default.
- W4224132967 cites W2168430695 @default.
- W4224132967 cites W2168564353 @default.
- W4224132967 cites W2170962119 @default.
- W4224132967 cites W2203404302 @default.
- W4224132967 cites W2260711886 @default.
- W4224132967 cites W2297053275 @default.
- W4224132967 cites W2341273205 @default.
- W4224132967 cites W2510661649 @default.
- W4224132967 cites W2514573576 @default.
- W4224132967 cites W2565264763 @default.
- W4224132967 cites W2605025138 @default.
- W4224132967 cites W2799380326 @default.
- W4224132967 cites W2882327091 @default.
- W4224132967 cites W2890809709 @default.
- W4224132967 cites W2897063798 @default.
- W4224132967 cites W2899248521 @default.
- W4224132967 cites W2901204587 @default.
- W4224132967 cites W2912335857 @default.
- W4224132967 cites W2980175514 @default.
- W4224132967 cites W3000442659 @default.
- W4224132967 cites W3004470256 @default.
- W4224132967 cites W3008788093 @default.
- W4224132967 cites W3010879168 @default.
- W4224132967 cites W3016443966 @default.
- W4224132967 cites W3021222207 @default.
- W4224132967 cites W3025501607 @default.
- W4224132967 cites W3049758936 @default.
- W4224132967 cites W3082120157 @default.
- W4224132967 cites W3093779021 @default.
- W4224132967 cites W3105070630 @default.
- W4224132967 cites W3127587557 @default.
- W4224132967 cites W3129700883 @default.
- W4224132967 cites W3130834559 @default.
- W4224132967 cites W3135510506 @default.
- W4224132967 cites W3163380833 @default.
- W4224132967 cites W3164067602 @default.
- W4224132967 cites W3175902545 @default.
- W4224132967 cites W3189407326 @default.
- W4224132967 cites W3193508436 @default.
- W4224132967 cites W4250928742 @default.
- W4224132967 doi "https://doi.org/10.1101/2022.04.13.22273676" @default.
- W4224132967 hasPublicationYear "2022" @default.
- W4224132967 type Work @default.
- W4224132967 citedByCount "1" @default.
- W4224132967 countsByYear W42241329672022 @default.
- W4224132967 crossrefType "posted-content" @default.
- W4224132967 hasAuthorship W4224132967A5003658474 @default.
- W4224132967 hasAuthorship W4224132967A5010908187 @default.
- W4224132967 hasAuthorship W4224132967A5014427334 @default.
- W4224132967 hasAuthorship W4224132967A5016395305 @default.
- W4224132967 hasAuthorship W4224132967A5018137195 @default.
- W4224132967 hasAuthorship W4224132967A5021010552 @default.
- W4224132967 hasAuthorship W4224132967A5021220009 @default.
- W4224132967 hasAuthorship W4224132967A5024781162 @default.